Investigation of the Synergic Effect of the Colistin/Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods

被引:0
|
作者
Kilbas, Imdat [1 ]
Hatipoglu, Huseyin [1 ]
Kilic, Umit [1 ]
Kahraman Kilbas, Elmas Pinar [2 ]
Koroglu, Mehmet [1 ]
Altindis, Mustafa [1 ]
机构
[1] Sakarya Univ, Dept Med Microbiol, Fac Med, Sakarya, Turkey
[2] Fenerbahce Univ, Vocat Sch Hlth Serv, Dept Med Lab Tech, Istanbul, Turkey
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2021年 / 26卷 / 01期
关键词
Acinetobacter baumannii; Colistin; Sulbactam; Synergy; Time-kill; Checkerboard; MULTIDRUG-RESISTANT; COLISTIN; SULBACTAM; MEROPENEM; EFFICACY; EPIDEMIOLOGY; MECHANISMS; IMIPENEM;
D O I
10.5578/flora.20219916
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Infections caused by carbapenem-resistant Acinetobacter strains have become very common in recent years, and the most frequently used medicinal treatment is colistin. Combination treatments should also be applied to prevent development of resistance to colistin. This study examines the in vitro synergic effect of the colistin/sulbactam combination in carbapenem-resistant Acinetobacter strains with the time-kill and checkerboard methods. Materials and Methods: Twenty carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex strains, which were isolated from various clinical samples, were included in this study. Strains were identified with mass spectrometry, and antibiotic sensitivity results were determined with the VITEK 2 (R) system. The in vitro effect and synergic activity of the colistin, sulbactam, and colistin/sulbactam combination on the carbapenem-resistant strains were determined using the time-kill and checkerboard methods. Seventeen strains were examined with the time-kill method, and twenty strains were examined using the checkerboard method. The fractional inhibitory concentration index of strains was calculated for detection of synergic effect. Results: Using the time-kill method applied on the colistin/sulbactam combination showed that the combination had a synergic effect on all 17 strains, while sulbactam alone did not have a bactericidal effect in the studied concentrations. When applying the checkerboard method, it was determined that the colistin/sulbactam combination had a synergic effect on 17 of the strains (85%) and an additive effect on 3 strains (15%), sulbactam had a low effect alone (15%), and colistin was effective on all strains. Conclusion: Study results indicated that the colistin/sulbactam combination had a high level of synergic effect on all studied strains using both methods.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 50 条
  • [1] Evaluation of the Efficacy of Colistin/Sulbactam Combination on Carbapenem-Resistant Acinetobacter baumannii Strains
    Cetinkol, Yeliz
    Telli, Murat
    Altuncekic Yildirim, Arzu
    Calgin, Mustafa Kerem
    MIKROBIYOLOJI BULTENI, 2016, 50 (03): : 460 - 465
  • [2] Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
    Bian, Xingchen
    Liu, Xiaofen
    Feng, Meiqing
    Bergen, Phillip J.
    Li, Jian
    Chen, Yuancheng
    Zheng, Huajun
    Song, Sichao
    Zhang, Jing
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (02)
  • [3] Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis
    Dinc, Gokcen
    Demiraslan, Hayati
    Elmali, Ferhan
    Ahmed, Salman Shaheer
    Metan, Gokhan
    Alp, Emine
    Doganay, Mehmet
    CHEMOTHERAPY, 2013, 59 (05) : 325 - 329
  • [4] Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
    Bian, Xingchen
    Li, Mengyao
    Liu, Xiaofen
    Zhu, Yan
    Li, Jian
    Bergen, Phillip J.
    Li, Wanzhen
    Li, Xin
    Feng, Meiqing
    Zhang, Jing
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2024, 23 : 2595 - 2605
  • [5] Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method
    Hatipoglu, Huseyin
    Kilbas, Imdat
    Kilic, Umit
    Yilmaz, Kerem
    Koroglu, Mehmet
    Altindis, Mustafa
    CLINICAL LABORATORY, 2018, 64 (11-12) : 1875 - 1881
  • [6] A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii
    Marie, Mohammed Ali M.
    Krishnappa, Lakshmana Gowda
    Alzahrani, Alhusain J.
    Mubaraki, Murad A.
    Alyousef, Abdullah A.
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 15 (04) : 24 - 29
  • [7] Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays
    Bozkurt-Guzel, Cagla
    Inci, Gozde
    Oyardi, Ozlem
    Savage, Paul B.
    CURRENT MICROBIOLOGY, 2020, 77 (08) : 1419 - 1428
  • [8] Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains
    Cikman, Aytekin
    Ceylan, Mehmet Resat
    Parlak, Mehmet
    Karahocagil, Mustafa Kasim
    Berktas, Mustafa
    MIKROBIYOLOJI BULTENI, 2013, 47 (01): : 147 - 151
  • [9] Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance
    Laishram, Shakti
    Anandan, Shalini
    Devi, Bakthavatchalam Yamuna
    Elakkiya, Munusamy
    Priyanka, Babu
    Bhuvaneshwari, Thukkaram
    Peter, John Victor
    Subramani, Kandasmy
    Balaji, Veeraraghavan
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (04) : 297 - 303
  • [10] Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii Infections
    Nyamagoud, Sanatkumar Bharamu
    Swamy, Agadi Hiremath Viswanatha
    Abhishek, B. J.
    Varghese, Leena Elizabeth
    Bhoomika, S. K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (02) : 289 - 298